Overview
Join us to explore how artificial intelligence is transforming the field of longevity medicine—from early detection and prevention of age-related diseases to personalized health optimization. Experts will discuss cutting-edge AI applications in biomarker discovery, predictive modeling, and precision therapeutics, and how these innovations are reshaping the future of healthy aging.
Programme:
3.00pm - 3.30pm: Registration and Check-in
3.30pm - 4.30pm: Panel Discussion and Q&A
4.30pm - 5.30pm: Networking
Public transportation:
The nearest MRT station: Orchard Mrt within a 15 min walk to Shaw Centre.
Parking Instructions: Shaw Centre Carpark is available to the public.
The parking rate on Mondays to Sundays is approximately $2 for first hour and $1.50 for subsequent hour (3.01 am – 6.00 pm).
Schedule
Date: 28 May 2025, Wednesday
Time: 3:00 PM - 5:30 PM (GMT +8:00) Kuala Lumpur, Singapore
Location: American Chamber Of Commerce (AmChamSG) 1 Scotts Rd, Shaw Centre Level 23, 228208
Speakers
Moderator's Profile:
Assoc Prof Daniel Ting, Director, AI Office, SingHealth
Dr Daniel Ting is the Associate Professor with Duke-NUS Medical School and Stanford University, senior consultant vitreo-retinal surgeon at the Singapore National Eye Center, Director of Singapore Health Service AI Office, and Associate Editor of npj Digital Medicine. His research focus is related to AI and digital health related applications for eye and retinal diseases that span across machine learning, deep learning, privacy preserving technology such as blockchain technology, federated machine learning and generative adversarial network, conversational AI chatbot using natural language processing.
Speaker's Profile:
Prof Dean Ho, Director, Institute for Digital Medicine NUS Yong Loo Lin School of Medicine
Prof. Ho and team also manage a portfolio of over 10 prospective, interventional human oncology clinical trials with life-saving outcomes. A serial entrepreneur, he has advised health/human performance teams, nutrition and wearable firms, and venture funds on digital medicine deployment. Prof. Ho is an elected Fellow of the US National Academy of Inventors (NAI), American Association for the Advancement of Science (AAAS), the American Institute for Medical and Biological Engineering (AIMBE), and the Royal Society of Chemistry. Prof. Ho is Co-Chair of the World Health Organization (WHO) Working Group for the regulation of AI for Health.
Speaker's Profile:
Prof Andrea Britta Maier, Co-founder, Chi Longevity
Professor Andrea B. Maier is a co-founder of Chi Longevity, an evidence-based, tech-enabled healthy longevity clinic. A renowned clinician scientist, she leads in optimising health across the lifespan, focusing on the interplay between ageing biology, chronic diseases, and clinical practice. She has over 440 peer-reviewed publications and holds advisory roles with the UN, WHO, Hevolution, and other global health bodies. Founding past President of the Healthy Longevity Medicine Society and holding professorships at prestigious universities, she is a sought-after advisor shaping the future of healthy longevity medicine worldwide.
Speaker's Profile:
Veronika Linardi, Co-founder, Eternami
Veronika Linardi, a serial entrepreneur and founder, has carved a distinctive path in the world of business with a profound commitment to sustainability. As the driving force behind her Single Family Office, she has set her sights on alternative investments in high-growth emerging markets. Sustainability is at the heart of her investment philosophy, aligning perfectly with the global shift toward responsible business practices. At the forefront of her endeavors is the establishment of a highly profitable tech-enabled ecosystem in Southeast Asia. This expansive ecosystem spans critical sectors, encompassing Electric Vehicles, logistics, supply chain management, and commerce infrastructure. Beyond her entrepreneurial ventures, Veronika co-founded one of Indonesia's largest Human Capital development companies. This transformative initiative has not only impacted the lives of millions but has also played a pivotal role in shaping Indonesia's future workforce.
Speaker's Profile:
Assoc Prof Jeremy Lim, CEO, AMILI
Jeremy is a medical doctor dually trained in surgery and public health. He is CEO and Co-Founder of AMILI, a microbiome insights company that harnesses AI to design and develop microbiome-based products and services to improve human health. He is also faculty in National University of Singapore and Monash University Malaysia amongst various roles in for profit and non-profit organizations.
Partners
